Principal investigator

Garry Duffy

Head of Department · Principal Investigator

Translational medicine · Medical devices · Chronic wound technologies · Infusion technologies

Email Garry RCSI profile Google Scholar Scopus

About

Research profile

Professor Garry Duffy heads RCSI Anatomy and Regenerative Medicine. His work spans translational medicine, medical devices, technology transfer and commercialisation.

Expertise

Research interests

01Translational medicine

02Medical devices

03Chronic wound technologies

04Infusion technologies

05Regenerative medicine

06Commercial translation

Lab members

Garry’s research team

Browse PI groups

No lab members are currently listed.

Selected outputs

Highlighted publications

All publications by this PI

2023Acta biomaterialia

Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing.

Castaño IM, Raftery RM, Chen G, Cavanagh B, Quinn B, Duffy GP, Curtin CM, O'Brien FJ

Bone, cartilage, joint repair and PTOA Targeted therapeutic delivery Biomaterial scaffolds

DOI Article

2021JACC. Basic to translational science

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Rosalia L, Ozturk C, Shoar S, Fan Y, Malone G, Cheema FH, Conway C, Byrne RA, Duffy GP, Malone A, Roche ET, Hameed A

Cardiovascular regeneration Medical devices and implants

DOI Article

2021Drug delivery and translational research

Towards the use of localised delivery strategies to counteract cancer therapy-induced cardiotoxicities.

Monahan DS, Almas T, Wyile R, Cheema FH, Duffy GP, Hameed A

Cardiovascular regeneration Advanced disease models Targeted therapeutic delivery

DOI Article

2021Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity.

Monahan DS, Flaherty E, Hameed A, Duffy GP

Cardiovascular regeneration

DOI Article

2020Acta biomaterialia

Rapid bone repair with the recruitment of CD206(+)M2-like macrophages using non-viral scaffold-mediated miR-133a inhibition of host cells.

Castaño IM, Raftery RM, Chen G, Cavanagh B, Quinn B, Duffy GP, O'Brien FJ, Curtin CM

Antimicrobial and immunomodulatory materials Bone, cartilage, joint repair and PTOA Biomaterial scaffolds

DOI Article

2020Acta biomaterialia

Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions.

Gallagher LB, Dolan EB, O'Sullivan J, Levey R, Cavanagh BL, Kovarova L, Pravda M, Velebny V, Farrell T, O'Brien FJ, Duffy GP

Hydrogels

DOI Article

Industry & translation

Turning research into impact.

TERG works with academic, clinical and industry partners to move biomaterials, devices and regenerative technologies towards patient benefit.

Industry, spin-outs and collaboration

Contact

Start a conversation.

For research, collaboration and supervision enquiries, email garryduffy@rcsi.com.

Lab contact details